Core Viewpoint - Xiamen International Trade Group has reported a significant decline in revenue and net profit for 2024, with a focus on improving supply chain management and health technology business performance in 2025 [1][2][3][4]. Financial Performance - In 2024, the company achieved operating revenue of 354.44 billion yuan, a decrease of 24.30% year-on-year, and a net profit attributable to shareholders of 626 million yuan, down 67.33% year-on-year [1]. - The net cash flow from operating activities was -931 million yuan, compared to 3.206 billion yuan in the same period of 2023 [1]. - Basic earnings per share were 0.04 yuan, a decline of 93.75% year-on-year, and the weighted average return on equity was 0.37%, down 6.28 percentage points year-on-year [1]. Quarterly Performance - In Q4 2024, the company reported operating revenue of 68.11 billion yuan, an increase of 0.86% year-on-year but a decrease of 25.25% quarter-on-quarter [1]. - The net profit attributable to shareholders in Q4 was -8.6 million yuan, compared to a profit of 4.9 million yuan in the same period of 2023, although the loss narrowed [1]. - For Q1 2025, the company achieved operating revenue of 70.53 billion yuan, a decrease of 27.19% year-on-year but an increase of 3.56% quarter-on-quarter, with a net profit of 422 million yuan, up 2.76% year-on-year [1]. Supply Chain Management - In 2024, the supply chain management business generated revenue of 353.22 billion yuan, down 24.09% year-on-year, with overseas revenue of 65.86 billion yuan and total import-export volume of 14.418 billion USD [2]. - The overall gross margin for the supply chain management business improved to 1.83%, an increase of 0.36 percentage points year-on-year, despite a decline in operating volume for major categories [2]. - Key product categories such as iron ore, steel, and coal maintained strong market positions, with significant improvements in gross margins [2]. Health Technology Business - The health technology segment reported revenue of 1.103 billion yuan in 2024, a growth of 49.61% year-on-year, with a gross margin of 41.04%, up 16.31 percentage points [3]. - The subsidiary, Paiter Medical, achieved revenue of 584 million yuan, a year-on-year increase of 15.42%, with over 50% of its revenue coming from overseas markets [3]. Shareholder Returns - The company announced a cash dividend of 0.33 yuan per share for 2024, totaling 715 million yuan, which represents 114.32% of the annual net profit attributable to shareholders, with a year-on-year increase in the dividend payout ratio of 56.76 percentage points [4]. - For 2025, the company plans to continue mid-term cash dividends, with amounts not exceeding 50% of the net profit attributable to shareholders for the corresponding period [4]. Profit Forecast and Valuation - The profit forecast for 2025-2027 has been adjusted, with expected net profits of 1.359 billion yuan, 1.657 billion yuan, and 1.976 billion yuan respectively [4]. - The projected earnings per share for 2025-2027 are 0.63 yuan, 0.76 yuan, and 0.91 yuan, with the current stock price at 6.27 yuan, resulting in corresponding price-to-earnings ratios of 10.0X, 8.2X, and 6.9X [4].

证券研究报告 交通运输 | 物流 非金融|公司点评报告 证券分析师 孙延 SAC：S1350524050003 sunyan01@huayuanstock.com 王惠武 SAC：S1350524060001 wanghuiwu@huayuanstock.com 曾智星 SAC：S1350524120008 zengzhixing@huayuanstock.com 张付哲 zhangfuzhe@huayuanstock.com 市场表现： | 收盘价（元） | | 6.14 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 一 年 内 高 最 低 | / | 8.29/5.46 | 最 | | | | | | （元） | | | | | | | | | 总市值（百万元） | | 13,308.23 | | | | | | | 流通市值（百万元） | | 13,091.45 | | | | | | | 总股本（百万股） | | 2,167.46 | | | | | | | 资产负债率（%） | | 67.35 | | | | | | ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600755 证券简称：厦门国贸 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人高少镛、主管会计工作负责人余励洁及会计机构负责人（会计主管人员）宋淑红保证季度报 告中财务信息的真实、准确、完整。 第一季度财务报表是否经审计 2025年第一季度，公司实现营业收入705.34亿元，同比下降27.19%，实现归属于上市公司股东的净利润 4.22亿元，同比增长2.76%。受大宗商品价格波动和公司业务结构调整的综合影响，公司营收规模有所 下降，但公司供应链管理业务积极贯彻"三链融合"发展新模式，聚焦高质量业务发展，主要经营品种的 经营质量和盈利能力稳中有进，对公司整体业绩企稳回升起到积极作用。 公司将继续落实 "十四五"战略规划要求，推进"三链融合"业务模式升级，坚持业务转型、模式创新， 打造差异化核心竞 ...

Group 1 - The core viewpoint of the articles highlights Xiamen Guomao's strong performance in Q1 2025, achieving a revenue of 70.534 billion yuan and a net profit of 422 million yuan, marking a year-on-year growth of 2.76% [1] - The company reported a significant improvement in operational quality, with a gross margin increase of 0.32 percentage points to 2.01% in Q1 2025, indicating enhanced profitability [1] - Xiamen Guomao is committed to implementing its "14th Five-Year" strategic plan, focusing on business transformation and innovation to build differentiated core competitiveness [1] Group 2 - The company has been actively advancing its strategic planning in Q1, signing a "total-to-total" agreement with Liaoning Port Co., Ltd. to enhance collaboration in logistics and create customized port logistics service solutions [2] - A strategic cooperation agreement was signed with Antong Holdings to transition from single business cooperation to ecological collaboration, focusing on container logistics and supply chain finance [2] - The company has initiated a cooperation project with Huaxiang (China) High Fiber Co., Ltd. to strengthen resource acquisition capabilities in the chemical fiber industry and has obtained qualifications for designated delivery warehouses for corn futures at Dalian Commodity Exchange [2]

点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 深化"三链融合"，加速推进国际化布局 公司持续深化"三链融合"，推动业务由供应链贸易向产业链运营和供应链服务转型升级。公司通过成立合资公 司、股权换商权等方式，开拓焦煤、焦炭全产业链布局，拓展光伏铝型材加工业务，开拓电解铝、氧化铝等业 务。同时公司落地山东日照国贸物流园项目，以"公铁水仓+智慧物流园"为核心，开展黑色、有色及能化等大 宗商品的综合物流服务。国际化发展方面，公司正式成立国际化发展部，同时已与170多个国家和地区的9万余 家产业链上下游企业建立稳定的合作关系，形成覆盖全球大宗商品资源的渠道网络。2024年，公司在海外地区 实现营收662亿元，同比增长0.67%，对应营收占比同比提升4.6pct至18.7%。 事件： 公司发布 ...